-
The fact that The Joint Commission had to recently issue a Sentinel Event Alert underscoring leadership's critical role in patient safety and quality care is "somewhat sad," notes Ronald B. Goodspeed, MD, MPH, FACP, FACPE, an instructor on health care management in the department of health policy and management, Harvard School of Public Health and former president of the Massachusetts Coalition for the Prevention of Medical Errors.
-
Looking at the historically low compliance numbers surrounding hand hygiene, Stephen Weber, MD, Joint Commission consultant and chief health care epidemiologist at the University of Chicago Medical Center, can only shake his head.
-
HIV antiretroviral adherence interventions have been broadly employed in the roughly dozen years since medication adherence became an issue. Interventions have combined medical and behavioral science, sometimes pairing technological innovation with conventional socio-behavioral counseling and education.
-
Researchers and clinicians working on medication adherence interventions have a variety of technological tools to help them both measure and, theoretically, improve medication adherence.
-
HIV stigma has existed since the world first learned about AIDS, and it's been commonly discussed, but clinicians still need to know more about its impact on their patients' well-being, adherence, and behaviors.
-
Study released on AIDS vaccine results from Thailand; Texas surgeon agrees to treat HIV/AIDS patients
-
The Centers for Disease Control and Prevention recently updated guidance on H1N1 pandemic influenza A and adults with HIV Infection. The latest Q&A postings on vaccination and treatment issues are summarized as follows.
-
It is essential to sustain a robust HIV/AIDS research agenda to develop interventions which have the potential to be "truly transforming," researchers report.
-
On Aug. 6, 2009, the FDA granted tentative approval for a generic formulation of lamivudine tablets, 150 mg and 300 mg, manufactured by Strides Arcolab Limited of Bangalore, India, indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
-
Women, as the Chinese proverb observes, are "half the sky." Unfortunately, they are also now half of the HIV/AIDS epidemic.
